Method for detecting carbapenem-resistant gram-negative bacilli

By mixing and incubating the strain to be tested with carbapenem antibiotic broth culture medium of carbapenem antibiotics in a specific volume ratio, observing bacterial precipitation and mass spectrometry identification, the carbapenem-resistant Gram-negative bacillus in the prior art was solved. The problems of long detection time, high cost and limited detection range have achieved rapid, accurate and economical detection of multiple drug-resistant strains.

CN118957018APending Publication Date: 2024-11-15JINAN JINYU MEDICINE JIANYAN CENT CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411383457.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-30
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The existing detection methods of carbapenem-resistant Gram-negative bacillus have problems such as long detection time, high cost, cumbersome operation or false negative results, and lack an accurate, fast and economical detection method, especially for non-government. The strains of Enterobacteriaceae are not tested well.

Method used

By mixing and incubating the strain to be tested with broth culture medium containing a certain concentration of carbapenem antibiotics at a specific volume ratio, observe whether there is bacterial precipitation. If so, mass spectrometry is used to identify it and determine it as carbapenem resistant Gram-negative bacillus, if not, is carbapenem-sensitive bacteria. This method is suitable for screening a variety of Gram-negative bacilli, with a wide coverage, high accuracy and short detection time.

Benefits of technology

It realizes rapid and accurate detection of carbapenem-resistant Gram-negative bacilli, reduces detection costs, is suitable for clinical microbial laboratories, has a short test time and is simple to operate, and is suitable for a variety of common drug-resistant strains.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005070466920000081
    Figure BDA0005070466920000081
  • Figure BDA0005070466920000091
    Figure BDA0005070466920000091
  • Figure BDA0005070466920000101
    Figure BDA0005070466920000101
Patent Text Reader

Abstract

The invention discloses a method for detecting carbapenem-resistant gram-negative bacilli, which comprises the following steps: inoculating a bacterial suspension of a strain to be detected into a bouillon culture medium containing carbapenem antibiotics, and incubating; the volume ratio of the bacterial suspension of the strain to be detected to the bouillon culture medium is (2.9-3.1): 2; and centrifuging, observing whether thalli precipitate exists, and if thalli precipitate exists, carrying out mass spectrum identification, so that the identified strain is carbapenem-resistant gram-negative bacillus. The detection method disclosed by the invention is suitable for screening carbapenem-resistant escherichia coli, klebsiella pneumoniae, acinetobacter baumannii, pseudomonas aeruginosa and other gram-negative bacilli such as proteus mirabilis, and is wide in strain coverage, high in accuracy, short in detection time, simple and convenient to operate, high in sensitivity, high in sensitivity, high in sensitivity and high in sensitivity. And the kit can assist the clinical detection of carbapenem-resistant gram-negative bacilli.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of molecular biology, and more specifically, the present invention relates to a method for detecting carbapenem-resistant Gram-negative bacilli. Background Art

[0002] Gram-negative bacteria resistant to carbapenems (mainly ertapenem, meropenem, and imipenem) are widely spread around the world and have become a global public health issue of common concern, seriously threatening human health. The World Health Organization (WHO) has listed carbapenem-resistant Gram-negative bacteria (CRO) such as Acinetobacter baumannii, Pseudomonas aeruginosa, Escherichia coli, and Klebsiella pneumoniae as "priority" resistant bacteria in the list of priority resistant pathogens that urgently need new antibiotics worldwide. They are the primary pathogens for resistance-related deaths. Therefore, accurate detection methods for carbapenem-resistant Gram-negative bacteria are particularly important.

[0003] At present, the commonly used methods for identifying carbapenem-resistant Gram-negative bacteria include antimicrobial susceptibility testing, Carba NP test, colloidal gold method, PCR gene detection and mass spectrometry. Antimicrobial susceptibility testing is a commonly used and reliable method for clinical microbiology, but since the corresponding carbapenem antibiotic paper strips are required for cultivation, the detection time is long (18h-24h) and the workload is also large; the advantage of the CarbaNP test is that it has a wide range of bacterial detection, but the disadvantage is that special reagents are required and the results are prone to false negatives; the advantages of the colloidal gold method are simple operation, rapid and efficient, and high sensitivity, but the disadvantage is that the cost is too high; the advantages of PCR gene detection are rapid and accurate, but the disadvantage is that it is expensive and requires high test conditions; and the mass spectrometry method is relatively new, and can quickly screen carbapenemase-producing Enterobacteriaceae strains by hydrolyzing carbapenem antibiotics to change their antibiotic characteristic peaks; or quickly identify carbapenem-resistant bacteria by detecting the protein characteristic peaks of resistant strains. However, the disadvantage is that there are only a few studies on a certain carbapenemase and there is no unified and feasible method; and the enzymatic hydrolysis method requires the preparation of an antimicrobial solution as a substrate for co-incubation with the test bacteria, and the disappearance of the characteristic peak of the antibiotic is required to judge whether it produces carbapenemase. The operation is cumbersome and not suitable for routine use in clinical microbiology laboratories. At present, these two methods have only been used to study carbapenem-resistant Enterobacteriaceae, and other common carbapenem-resistant Gram-negative bacteria such as Acinetobacter baumannii and Pseudomonas aeruginosa have not been tested.

[0004] Therefore, it is very necessary to provide a method for detecting carbapenem-resistant Gram-negative bacilli that is accurate, time-saving and low-cost. Summary of the invention

[0005] Based on this, the object of the present invention is to provide a method for detecting carbapenem-resistant Gram-negative bacilli. The detection method of the present invention can accurately detect carbapenem-resistant Gram-negative bacilli, and is time-saving and low-cost.

[0006] The technical solutions for achieving the above-mentioned invention objectives include the following.

[0007] The present invention discloses a method for detecting carbapenem-resistant Gram-negative bacilli, comprising the following steps:

[0008] (1) The concentration is 1×10 8 CFU / mL~2×10 8 CFU / mL of the strain suspension to be tested is inoculated into a broth medium containing carbapenem antibiotics and incubated; the volume ratio of the strain suspension to be tested to the broth medium is 2.9-3.1:2; the concentration of the carbapenem antibiotics in the broth medium is 18μg / mL-22μg / mL;

[0009] (2) Centrifuge and observe whether there is bacterial precipitation. If there is bacterial precipitation, mass spectrometry identification is performed to identify the strain as a carbapenem-resistant Gram-negative bacillus.

[0010] After repeated experiments and explorations, the inventors of the present invention found that after the bacterial suspension of the strain to be tested and the culture medium containing a certain concentration of carbapenem antibiotics (at this concentration, the growth of carbapenem-sensitive Gram-negative bacteria can be 100% inhibited) are mixed at a certain volume ratio (at this volume, the growth of carbapenem-resistant Gram-negative bacteria can be 100% inhibited, and it is not pseudo-resistance) for culture, and then centrifuged, and whether there is bacterial precipitation is observed by naked eye. If there is bacterial precipitation, the bacterial precipitation is then subjected to traditional mass spectrometry identification (without studying the characteristic peaks of carbapenemase or antibiotic characteristic peaks). When the identified strain is the target strain, it can be confirmed that the strain to be tested is a carbapenem-resistant Gram-negative bacillus; if there is no bacterial precipitation, the strain to be tested is a carbapenem-sensitive Gram-negative bacillus.

[0011] The detection method of the present invention is suitable for screening carbapenem-resistant Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and other Gram-negative bacilli such as Proteus mirabilis. It covers a wide range of strains, has high accuracy, short detection time, and is simple and convenient to operate. It can assist in the detection of carbapenem-resistant Gram-negative bacilli in clinical practice. BRIEF DESCRIPTION OF THE DRAWINGS

[0012] Figure 1 This is the mass spectrometry identification diagram of Escherichia coli SHBCC 25219 (bacterial suspension: culture medium = 3:2) in Test Example 2 of the present invention.

[0013] Figure 2This is the mass spectrometry identification diagram of Klebsiella pneumoniae ATCC BAA1705 (bacterial suspension: culture medium = 1:4) in Test Example 2 of the present invention.

[0014] Figure 3 This is the mass spectrometry identification diagram of Klebsiella pneumoniae ATCC BAA1705 (bacterial suspension: culture medium = 3:2) in Test Example 2 of the present invention.

[0015] Figure 4 This is the mass spectrometry identification diagram of Pseudomonas aeruginosa SHBCC D25221 (bacterial suspension: culture medium = 2:3) in Test Example 2 of the present invention.

[0016] Figure 5 This is the mass spectrometry identification diagram of Pseudomonas aeruginosa SHBCC D25221 (bacterial suspension: culture medium = 3:2) in Test Example 2 of the present invention.

[0017] Figure 6 This is the mass spectrometry identification diagram of Acinetobacter baumannii NCTC 13304 (bacterial suspension: culture medium = 1:1) in Test Example 2 of the present invention.

[0018] Figure 7 This is the mass spectrometry identification diagram of Acinetobacter baumannii NCTC 13304 (bacterial suspension: culture medium = 3:2) in Test Example 2 of the present invention. DETAILED DESCRIPTION

[0019] In order to facilitate the understanding of the present invention, the present invention will be described more fully below. The present invention can be implemented in many different forms and is not limited to the embodiments described herein. On the contrary, the purpose of providing these embodiments is to make the understanding of the disclosure of the present invention more thorough and comprehensive.

[0020] Unless otherwise defined, all technical and scientific terms used in the present invention have the same meaning as those commonly understood by those skilled in the art to which the present invention belongs. The terms used in the specification of the present invention are only for the purpose of describing specific embodiments and are not intended to limit the present invention. The term "and / or" used in the present invention includes any and all combinations of one or more of the related listed items.

[0021] The experimental methods in the following examples where specific conditions are not specified are generally carried out under conventional conditions, such as those described in Green and Sambrook et al., Molecular Cloning: A Laboratory Manual (2013), or according to the conditions recommended by the manufacturer. The various commonly used chemical reagents used in the examples are all commercially available products.

[0022] In some embodiments of the present invention, a method for detecting carbapenem-resistant Gram-negative bacilli is disclosed, comprising the following steps:

[0023] (1) The concentration is 1×10 8 CFU / mL~2×10 8 CFU / mL of the strain suspension to be tested is inoculated into a broth medium containing carbapenem antibiotics and incubated; the volume ratio of the strain suspension to be tested to the broth medium is 2.9-3.1:2; the concentration of the carbapenem antibiotics in the broth medium is 18μg / mL-22μg / mL;

[0024] (2) Centrifuge and observe whether there is bacterial precipitation. If there is bacterial precipitation, perform mass spectrometry identification, and the strain identified is a carbapenem-resistant Gram-negative bacillus; if there is no bacterial precipitation, the strain to be tested is a carbapenem-sensitive Gram-negative bacillus.

[0025] In some of the embodiments, the volume ratio of the test strain suspension to the broth culture medium in step (1) is 2.95-3.05:2, more preferably 3:2.

[0026] In some embodiments, the concentration of the test strain suspension in step (1) is 1×10 8 CFU / mL~1.5×10 8 CFU / mL.

[0027] In some embodiments, the concentration of the carbapenem antibiotics in the broth culture medium in step (1) is 19 μg / mL to 21 μg / mL, more preferably 20 μg / mL.

[0028] In some embodiments, the incubation temperature in step (1) is 35°C ± 1°C, and the incubation time is 4h to 8h.

[0029] In some embodiments, the centrifugal speed in step (2) is 10000 rpm to 14000 rpm, and the centrifugal time is 2 min to 4 min.

[0030] In some embodiments, the formula of the broth medium containing carbapenem antibiotics in step (1) is: peptone 8g / L~12g / L, beef extract 8g / L~12g / L, yeast extract 4g / L~6g / L, sodium chloride 4g / L~6g / L, carbapenem antibiotics 18μg / mL~22μg / mL, pH=7.0±0.2.

[0031] In some embodiments, a method for detecting carbapenem-resistant Gram-negative bacilli comprises the following steps:

[0032] (1) The concentration is 1×10 8 CFU / mL~2×10 8 CFU / mL of the strain suspension to be tested is inoculated into a broth medium containing carbapenem antibiotics, and incubated at 35±1°C for 4h to 8h; the volume ratio of the strain suspension to be tested to the broth medium is 3:2; the concentration of the carbapenem antibiotics in the broth medium is 20μg / mL;

[0033] (2) Centrifuge and observe whether there is bacterial precipitation. If there is bacterial precipitation, perform mass spectrometry identification, and the strain identified is a carbapenem-resistant Gram-negative bacillus; if there is no bacterial precipitation, the strain to be tested is a carbapenem-sensitive Gram-negative bacillus.

[0034] In some embodiments, the carbapenem antibiotics are ertapenem, meropenem and imipenem.

[0035] In some embodiments, the carbapenem-resistant Gram-negative bacilli include Acinetobacter baumannii, Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae or Proteus mirabilis.

[0036] The present invention is described in detail below with reference to the accompanying drawings and specific embodiments.

[0037] Example 1 Method for detecting carbapenem-resistant Gram-negative bacilli

[0038] The following steps are involved:

[0039] 1. Prepare liquid culture medium containing antibiotics. The formula of liquid culture medium is: peptone 10g / L, beef extract 10g / L, yeast extract 5g / L, sodium chloride 5g / L, 20μg / mL imipenem (IPM), pH = 7.0;

[0040] 2. According to the volume ratio of 3:2, the concentration of 1×10 8 CFU / ml of the strain suspension to be tested was inoculated into the above culture medium and incubated at 36°C for 6h;

[0041] 3. Centrifuge at 12000rpm for 2min. Observe with naked eyes whether there is bacterial precipitation. If there is bacterial precipitation, perform mass spectrometry identification, and the strain identified is a carbapenem-resistant Gram-negative bacillus. If there is no bacterial precipitation, the strain to be tested is a carbapenem-sensitive Gram-negative bacillus.

[0042] Example 2 Method for detecting carbapenem-resistant Gram-negative bacilli

[0043] The following steps are involved:

[0044] 1. Prepare liquid culture medium containing antibiotics. The formula of liquid culture medium is: peptone 10g / L, beef extract 10g / L, yeast extract 5g / L, sodium chloride 5g / L, 20μg / mL meropenem (MEM), pH = 7.0;

[0045] 2. According to the volume ratio of 3:2, the concentration of 2×10 8 CFU / ml of the strain suspension to be tested was inoculated into the above culture medium and incubated at 36°C for 6h;

[0046] 3. Centrifuge at 12000rpm for 2min to observe whether there is bacterial precipitation. If there is bacterial precipitation, perform mass spectrometry identification, and the strain identified is a carbapenem-resistant Gram-negative bacillus. If there is no bacterial precipitation, the strain to be tested is a carbapenem-sensitive Gram-negative bacillus.

[0047] Experimental Example 1: Exploration of effective antibacterial antibiotic concentration

[0048] This test example uses carbapenem antibiotic-sensitive strains (all commercially available model strains) as experimental strains to explore the concentration of carbapenem antibiotics that can effectively inhibit bacteria, specifically including the following steps:

[0049] 1. Prepare liquid culture medium containing different antibiotic concentrations: peptone 10g / L, beef extract 10g / L, yeast extract 5g / L, sodium chloride 5g / L, imipenem (IPM) or meropenem (MEM) (concentrations are 5μg / mL, 10μg / mL, 15μg / mL, 20μg / mL, 25μg / mL, respectively), pH = 7.0;

[0050] 2. The concentration of 6 strains was 1×10 8 A bacterial suspension of carbapenem-sensitive Gram-negative strains (Escherichia coli ATCC 25922, Escherichia coli ATCC 35218, Klebsiella pneumoniae ATCC 700603, Proteus mirabilis ATCC 35659, Pseudomonas aeruginosa ATCC 27853, Acinetobacter baumannii ATCC 19606) with a concentration of CFU / mL was inoculated into the above medium (bacterial suspension: medium = 3:2, total volume 1 mL), and incubated at 36°C for 6 h;

[0051] 3. After centrifugation at 12000rpm for 2min, observe with the naked eye whether there is bacterial precipitation. If there is bacterial precipitation, perform mass spectrometry identification on the bacterial precipitation (conventional mass spectrometry identification method: take 1μL of precipitation and apply it evenly on the target plate, add 1μL of lysis solution 1 (Antu Biological, lyse the cell wall and expose the intracellular protein) to dry, then add 1μL of matrix (Antu Biological) to dry; put the sample target into the mass spectrometer for identification). If there is no bacterial precipitation, take the culture solution for mass spectrometry identification (conventional mass spectrometry identification method: take 1μL of culture solution and apply it evenly on the target plate, add 1μL of lysis solution 1 (Antu Biological, lyse the cell wall and expose the intracellular protein) to dry, then add 1μL of matrix (Antu Biological) to dry; put the sample target into the mass spectrometer for identification). The results are shown in Table 1.

[0052] Table 1 Test results of effective antibacterial antibiotic concentration

[0053]

[0054] Note: N means it cannot be identified by mass spectrometry; Y means it can be identified by mass spectrometry

[0055] From the results in Table 1, it can be seen that when the culture medium contains 10 μg / mL of imipenem / meropenem, only Klebsiella pneumoniae ATCC 700603 and Pseudomonas aeruginosa ATC C 27853 among the six carbapenem-sensitive strains have no bacterial precipitation, and the mass spectrometry method has not identified the strains; the other strains have bacterial precipitation, and the mass spectrometry method has identified the strains; indicating that when the antibiotic concentration is 10 μg / mL, only 33% of the carbapenem-sensitive bacteria can be inhibited from growing, and the antibacterial effect is not ideal. With the increase of antibiotic concentration, the antibacterial effect is enhanced. When the antibiotic concentration in the culture medium increases to 20 μg / mL and 25 μg / mL, the growth of all carbapenem-sensitive strains is inhibited, and the effective antibacterial rate is 100%.

[0056] Therefore, the culture medium containing 20 μg / mL antibiotics can be used as a screening medium for carbapenem-resistant Gram-negative bacteria.

[0057] Experimental Example 2: Exploration of the volume ratio of bacterial suspension to culture medium for effective antibacterial effect

[0058] This test example uses carbapenem-resistant strains (all commercially available carbapenem-resistant strains purchased from Wuhan Huaerna Biological Co., Ltd.) as experimental strains, explores the volume ratio of bacterial suspension to culture medium, and specifically includes the following steps:

[0059] 1. Prepare liquid culture medium containing antibiotics. The formula of liquid culture medium is: 20 μg / mL imipenem (IPM) or 20 μg / mL meropenem (MEM), 10 g / L peptone, 10 g / L beef extract, 5 g / L yeast extract, 5 g / L sodium chloride, pH = 7.0;

[0060] 2. The concentration of 4 strains was 1×10 8 Carbapenem-resistant Gram-negative strains with CFU / mL - Escherichia coli SHBCC D25219 (resistant to imipenem and meropenem), Klebsiella pneumoniae ATCC BAA1705 (resistant to imipenem), Pseudomonas aeruginosa SHBCC D25221 (resistant to imipenem), Acinetobacter baumannii NCTC 13304 (resistant to meropenem) - were inoculated into the above culture medium according to the ratio of bacterial suspension: culture medium (total volume of 1 mL) = 1:9, 1:4, 3:7, 2:3, 1:1, 3:2, 7:3, and incubated at 36°C for 6 h;

[0061] 3. After centrifugation at 12000 rpm for 2 minutes, observe with the naked eye whether there is bacterial precipitation. If there is bacterial precipitation, perform mass spectrometry identification on the bacterial precipitation. If there is no bacterial precipitation, take the culture fluid for mass spectrometry identification. The results are shown in Table 2.

[0062] Table 2 Test results of effective antibacterial bacterial suspension: culture medium volume ratio

[0063]

[0064]

[0065] Note: N means it cannot be identified by mass spectrometry; Y means it can be identified by mass spectrometry.

[0066] From the results in Table 2, we can see that when the volume ratio of bacterial suspension to culture medium is 3:2 (the concentration of bacterial suspension is 6×10 7 CFU / mL) and 7:3 (the concentration of bacterial suspension was 7×10 7 CFU / mL), 100% of carbapenem-resistant Gram-negative bacteria could be screened using a culture medium containing 20 μg / mL of antibiotics.

[0067] Figure 1 to Figure 7 Some mass spectra at different volume ratios are shown. As can be seen from the figure, when the volume ratio of bacterial suspension to culture medium is 3:2, Escherichia coli SHBCC D25219, Klebsiella pneumoniae ATCC BAA1705, Pseudomonas aeruginosa SHBCCD25221 and Acinetobacter baumannii NCTC 13304 can all be identified by mass spectrometry as the corresponding bacterial species, proving that the above strains have developed drug resistance when the volume ratio of bacterial suspension to culture medium is 3:2 ( Figure 1 , Figure 3 , Figure 5 , Figure 7 ); when the volume ratio of the bacterial suspension of Klebsiella pneumoniae ATCCBAA1705 to the culture medium was 1:4, the volume ratio of the bacterial suspension of Pseudomonas aeruginosa SHBCC D25221 to the culture medium was 2:3, and the volume ratio of the bacterial suspension of Acinetobacter baumannii NCTC 13304 to the culture medium was 1:1, none of them were identified by mass spectrometry, indicating that the above strains did not develop drug resistance under this volume ratio ( Figure 2 , Figure 4 , Figure 6 ). Experimental Example 3 Volume ratio of bacterial suspension that can produce pseudo-resistance: culture medium

[0068] This test example uses carbapenem-sensitive strains Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 700603, Pseudomonas aeruginosa ATCC 27853, and Acinetobacter baumannii ATCC 19606 as experimental objects to verify whether false resistance will be generated due to excessive bacteria when the volume ratio of bacterial suspension to culture medium exceeds 3:2. The specific steps include:

[0069] 1. Prepare liquid culture medium containing antibiotics. The formula of liquid culture medium is: 20 μg / mL imipenem (IPM) or 20 μg / mL meropenem (MEM), 10 g / L peptone, 10 g / L beef extract, 5 g / L yeast extract, 5 g / L sodium chloride, pH = 7.0;

[0070] 2. The concentration of 4 strains was 1×10 8 Carbapenem-susceptible Gram-negative strains with CFU / mL, including Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 700603, Pseudomonas aeruginosa ATCC 27853, and Acinetobacter baumannii ATCC 19606, were inoculated into the above medium at a ratio of bacterial suspension: medium (total volume of 1 mL) of 3:2, 7:3, 4:1, and 9:1, and incubated at 36°C for 6 h;

[0071] 3. After centrifugation at 12000 rpm for 2 minutes, observe with the naked eye whether there is bacterial precipitation. If there is bacterial precipitation, perform mass spectrometry identification on the bacterial precipitation. If there is no bacterial precipitation, take the culture fluid for mass spectrometry identification. The results are shown in Table 3.

[0072] Table 3 Test results of volume ratio of bacterial suspension: culture medium that can produce false resistance

[0073]

[0074] Note: N means it cannot be identified by mass spectrometry; Y means it can be identified by mass spectrometry.

[0075] From the results in Table 3, it can be seen that when the volume ratio of bacterial suspension to culture medium is ≥7:3, Escherichia coli ATCC25922 has bacterial precipitation and is identified by mass spectrometry, indicating that the bacteria cannot be inhibited by carbapenem antibiotics at this volume ratio, and the bacteria are excessive at this volume ratio, which will produce false resistance (similarly, the true resistance of the strains that are resistant to the drug itself cannot be verified at a volume ratio exceeding 7:3). The probability that carbapenem-sensitive strains can produce false resistance to carbapenem antibiotics due to excessive bacteria is ≥25%.

[0076] Combining the results of Experimental Examples 2 and 3, it can be concluded that when the volume ratio of the bacterial suspension to the culture medium is 3:2, the accuracy of screening carbapenem-resistant Gram-negative bacilli reaches 100% using a culture medium containing 20 μg / mL antibiotics.

[0077] Experimental Example 4: Detection of clinical strains using the detection method of the present invention

[0078] Antimicrobial sensitivity tests were performed on 12 strains of Gram-negative bacteria screened clinically, including 3 strains of Escherichia coli (numbered: DC05, DC06, and DC76), 2 strains of Klebsiella pneumoniae (numbered: FK77 and FK99), 2 strains of Pseudomonas aeruginosa (numbered: TL09 and TL25), 2 strains of Acinetobacter baumannii (numbered: BM01 and BM31), and 3 strains of Proteus mirabilis (numbered: QY05, QY61, and QY65). Since Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis belong to the Enterobacteriaceae family, Acinetobacter baumannii belongs to the genus Acinetobacter, and Pseudomonas aeruginosa belongs to the genus Pseudomonas, the carbapenem antibiotic susceptibility breakpoints of the three are different. Imipenem (IPM) and meropenem (MEM) drug sensitivity papers were used to perform antimicrobial susceptibility tests on the above strains (conventional methods), and strains resistant to any of the carbapenem antibiotics were judged to be carbapenem-resistant strains. Table 4 shows the results of the antimicrobial susceptibility test.

[0079] Table 4 Results of antimicrobial susceptibility testing of clinical strains

[0080]

[0081]

[0082] Note: S is sensitive; I is intermediate; R is resistant.

[0083] From the results in Table 4, it can be seen that the carbapenem-resistant strains screened by antimicrobial susceptibility test are: Escherichia coli DC06, Klebsiella pneumoniae FK77, Proteus mirabilis QY05, Proteus mirabilis QY65, Pseudomonas aeruginosa TL09 and Acinetobacter baumannii BM31, and the other 6 strains are carbapenem-sensitive strains.

[0084] The above 12 strains were detected using the detection method of Example 1. The results showed that Escherichia coli DC06, Klebsiella pneumoniae FK77, Proteus mirabilis strain QY05, Proteus mirabilis strain QY65, Pseudomonas aeruginosa TL09 and Acinetobacter baumannii BM31 had bacterial precipitation and could be identified by mass spectrometry, while the remaining 6 strains were not identified by mass spectrometry.

[0085] Therefore, the clinical strains were tested using the antimicrobial susceptibility test commonly used in the art and the detection method of the present invention, and the results of the carbapenem-resistant strains screened out were completely consistent, with an accuracy of 100%, proving that the detection method of the present invention is feasible for screening carbapenem-resistant Gram-negative bacteria.

[0086] The technical features of the above-described embodiments may be arbitrarily combined. To make the description concise, not all possible combinations of the technical features in the above-described embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0087] The above-mentioned embodiments only express several implementation methods of the present invention, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the invention patent. It should be pointed out that, for ordinary technicians in this field, several variations and improvements can be made without departing from the concept of the present invention, and these all belong to the protection scope of the present invention. Therefore, the protection scope of the patent of the present invention shall be subject to the attached claims.

Claims

1. A method for detecting carbapenem-resistant Gram-negative bacilli, characterized in that: The following steps are involved: (1) The concentration is 1×10 8 CFU / mL~2×10 8 CFU / mL of the strain suspension to be tested is inoculated into a broth medium containing carbapenem antibiotics and incubated; the volume ratio of the strain suspension to be tested to the broth medium is 2.9-3.1:2; the concentration of the carbapenem antibiotics in the broth medium is 18μg / mL-22μg / mL; (2) Centrifuge and observe whether there is bacterial precipitation. If there is bacterial precipitation, mass spectrometry identification is performed to identify the strain as a carbapenem-resistant Gram-negative bacillus.

2. The method for detecting carbapenem-resistant Gram-negative bacilli according to claim 1, characterized in that: The volume ratio of the test strain suspension to the broth culture medium in step (1) is 2.95-3.05:2, more preferably 3:

2.

3. The method for detecting carbapenem-resistant Gram-negative bacilli according to claim 1, characterized in that: The concentration of the carbapenem antibiotics in the broth culture medium in step (1) is 19 μg / mL to 21 μg / mL, more preferably 20 μg / mL.

4. The method for detecting carbapenem-resistant Gram-negative bacilli according to any one of claims 1 to 3, characterized in that: The concentration of the test strain suspension in step (1) is 1×10 8 CFU / mL~1.5×10 8 CFU / mL.

5. The method for detecting carbapenem-resistant Gram-negative bacilli according to any one of claims 1 to 3, characterized in that: The incubation temperature in step (1) is 35°C ± 1°C, and the incubation time is 4h to 8h.

6. The method for detecting carbapenem-resistant Gram-negative bacilli according to any one of claims 1 to 3, characterized in that: The centrifugal speed in step (2) is 10000 rpm to 14000 rpm, and the centrifugal time is 2 min to 4 min.

7. The method for detecting carbapenem-resistant Gram-negative bacilli according to any one of claims 1 to 3, characterized in that: The formula of the broth culture medium containing carbapenem antibiotics in step (1) is: peptone 8g / L~12g / L, beef extract 8g / L~12g / L, yeast extract 4g / L~6g / L, sodium chloride 4g / L~6g / L, carbapenem antibiotics 18μg / mL~22μg / mL, pH=7.0±0.

2.

8. The method for detecting carbapenem-resistant Gram-negative bacilli according to any one of claims 1 to 3, characterized in that: The carbapenem antibiotic is ertapenem, meropenem and / or imipenem.

9. The method for detecting carbapenem-resistant Gram-negative bacilli according to any one of claims 1 to 3, characterized in that: The carbapenem-resistant Gram-negative bacilli include Acinetobacter baumannii, Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae or Proteus mirabilis strains.

10. The method for detecting carbapenem-resistant Gram-negative bacilli according to claim 1, characterized in that: The following steps are involved: (1) The concentration is 1×10 8 CFU / mL~2×10 8 CFU / mL of the strain suspension to be tested is inoculated into a broth medium containing carbapenem antibiotics, and incubated at 35°C±1°C for 4h to 8h; the volume ratio of the strain suspension to be tested to the broth medium is 3:2; the concentration of the carbapenem antibiotics in the broth medium is 20μg / mL; (2) Centrifuge and observe whether there is bacterial precipitation. If there is bacterial precipitation, mass spectrometry identification is performed to identify the strain as a carbapenem-resistant Gram-negative bacillus.